Dr. Doris Leung, MD
Claim this profileKennedy Krieger Institute
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
9 reported clinical trials
10 drugs studied
Area of expertise
1Muscular Dystrophy
FKRP positive
LGMD2I/R9 positive
DMD
2Duchenne Muscular Dystrophy
FKRP positive
DMD
Duchenne mutation positive
Affiliated Hospitals
Clinical Trials Doris Leung, MD is currently running
Ribitol
for Limb-Girdle Muscular Dystrophy
This trial will test the safety and effectiveness of BBP-418 in patients aged 12 to 60 who have a specific type of muscular dystrophy called LGMD2I/R9. The goal is to see if this new treatment can help improve their condition over several months.
Recruiting1 award Phase 36 criteria
Oral Ifetroban
for Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a devastating X-linked disease which leads to loss of ambulation between ages 7 and 13, respiratory failure and cardiomyopathy (CM) at any age, and inevitably premature death of affected young men in their late twenties. DMD is the most common fatal genetic disorder diagnosed in childhood. It affects approximately 1 in every 3,500 live male births across all races and cultures, and results in 20,000 new cases each year worldwide.Significant advances in respiratory care have unmasked CM as the leading cause of death. As there are yet no specific cardiac treatments to extend life, the current study aims to address this unmet medical need using a new therapeutic strategy for patients with DMD. Funding Source - FDA OOPD
Recruiting0 awards Phase 23 criteria
More about Doris Leung, MD
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Doris Leung, MD has experience with
- Placebo
- Corticosteroids
- Pamrevlumab
- Motor Outcomes To Validate Evaluations In FSHD (MOVE FSHD)
- Ifetroban
- Observational Study
Breakdown of trials Doris Leung, MD has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Limb-Girdle Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy
Dilated Cardiomyopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Doris Leung, MD specialize in?
Doris Leung, MD focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved FKRP positive patients, or patients who are LGMD2I/R9 positive.
Is Doris Leung, MD currently recruiting for clinical trials?
Yes, Doris Leung, MD is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Doris Leung, MD has studied deeply?
Yes, Doris Leung, MD has studied treatments such as Placebo, Corticosteroids, Pamrevlumab.
What is the best way to schedule an appointment with Doris Leung, MD?
Apply for one of the trials that Doris Leung, MD is conducting.
What is the office address of Doris Leung, MD?
The office of Doris Leung, MD is located at: Kennedy Krieger Institute, Baltimore, Maryland 21205 United States. This is the address for their practice at the Kennedy Krieger Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.